Product Program year 2023 Source: CMS Open Payments

Lacrisert

Drug Ophthalmology

NDC 24208-800-60

Open in the dashboard

General payments

$34,083

17 payments

Research payments

$0

0 payments

Through program year 2023, $34,083 in general payments and $0 in research payments were reported against Lacrisert (Ophthalmology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2023 General $28 2
2022 General $110 4
2021 General $3,500 1
2019 General $30,444 10

Breakdown

Who paid General payments · program years 2019–2023
  1. Bausch & Lomb, a division of Bausch Health US, LLC $33,940 10 payments
  2. Bausch & Lomb Americas Inc. $86 3 payments
  3. Salix Pharmaceuticals, a division of Bausch Health US, LLC $57 4 payments
Top recipients General payments · program year 2023
  1. Steven Silverstein Ophthalmology · Kansas City, MO $14 50% · 1 payment
  2. Karl Stonecipher Ophthalmology · Greensboro, NC $14 50% · 1 payment

Each share is of general payments naming this product in 2023.

Specialties paid General payments · program year 2023
  1. Ophthalmology $28 100% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2023
  1. Missouri $14 50% · 1 recipient
  2. North Carolina $14 50% · 1 recipient

Each share is of general payments naming this product in 2023 where a state was reported.

17 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record